Phase II Study of SHR-A1811 for Ultra-Low HER2 Advanced Breast Cancer
Phase II Study of SHR-A1811 for Ultra-Low HER2 Advanced Breast Cancer
Recruiting · NCT07817082 · Registry updated 2026-09-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase II Study of SHR-A1811 for Ultra-Low HER2 Advanced Breast Cancer | Advanced Breast Cancer With Ultra-Low HER2 Expression | Recruiting | Phase 2 | 2026-09-14 | NCT07817082 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Tianjin Medical University Cancer Institute and Hospital | 287 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Tianjin Medical University Cancer Institute and Hospital | Tianjin | China | 36 |